Lead Integrity Testing During Tachyarrhythmia

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Implantable medical devices face challenges in accurately distinguishing between actual tachyarrhythmias and lead integrity issues, leading to potential inappropriate therapy delivery due to intermittent or continuous changes in lead impedance.

Innovation Solution

The implementation of a lead integrity test that measures impedance multiple times during suspected tachyarrhythmia events, comparing these measurements to baseline values to determine variability and evaluate the integrity of the lead, thereby differentiating between true tachyarrhythmias and lead-related issues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If lead impedance is monitored continuously to detect tachyarrhythmias, then detection sensitivity is improved, but false positives increase due to lead integrity issues

Engineering Contradiction:
Improvetachyarrhythmia detection accuracyVSAvoidfalse positive rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The system performs a lead integrity test before delivering therapy for suspected tachyarrhythmia. This preliminary action checks lead impedance stability and compares it to baseline values, identifying lead issues before they cause false positive therapy delivery. The integrity test includes measuring impedance at multiple points and determining variability to detect intermittent lead problems.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces an intermediary lead integrity assessment between tachyarrhythmia detection and therapy delivery. This intermediary step uses impedance variability analysis as a mediator to distinguish between true arrhythmias and lead-related false positives, preventing inappropriate therapy while maintaining sensitive detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If lead integrity testing is performed during suspected tachyarrhythmia, then false positive therapy is reduced, but therapy delivery time is delayed

Engineering Contradiction:
Improveappropriate therapy deliveryVSAvoidtherapy delivery delay
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system performs a focused lead integrity test that measures impedance at a limited number of critical points during the suspected tachyarrhythmia event rather than continuous monitoring. This partial action approach provides sufficient information to detect lead issues while minimizing the time added to therapy delivery, balancing reliability improvement with time loss.

Inventive Principle:
Principle #16Partial or excessive action

3Measurement precision

If impedance measurements are taken multiple times during tachyarrhythmia, then lead integrity assessment is improved, but energy consumption increases

Engineering Contradiction:
Improvelead integrity evaluation accuracyVSAvoiddevice energy consumption
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The system performs impedance measurements periodically at specific intervals during the suspected tachyarrhythmia event rather than continuously. This periodic action captures lead integrity status at critical moments while allowing energy conservation during intervals between measurements, reducing overall energy consumption while maintaining detection accuracy.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the withholding of therapy or reconfiguration of sensing settings to prevent inappropriate treatment, ensuring that interventions are targeted at actual arrhythmias rather than false positives caused by lead integrity problems.

Implementation Method 1

measuring an impedance of the lead a plurality of times during the suspected tachyarrhythmia

Methodology Applied
Scientific EffectImpedance measurement: Electrical Resistance

Data Source

PatentUS8849385B2Lead integrity testing during suspected tachyarrhythmias
Publication Date: 2014.09.30 MEDTRONIC INC
  • US8849385B2 patent drawing
  • US8849385B2 patent drawing
  • US8849385B2 patent drawing

AI summary

Techniques for performing a lead integrity test during a suspected tachyarrhythmia are described. An implantable medical device (IMD) may perform the test prior to delivering a therapeutic shock to treat the suspected tachyarrhythmia and, in some cases, may withhold the shock based on the test. In some examples, the IMD measures an impedance of a lead a plurality of times during the suspected tachyarrhythmia. In some examples, the IMD measures the impedance a plurality of times between two sensed events of the suspected tachyarrhythmia. The IMD or another device may determine a variability of, or otherwise compare, the measured impedances to evaluate the integrity of the lead. Instead of or in addition to withholding a shock, the IMD or another device may change a sensing or stimulation vector of the IMD, or provide an alert to a user, if the integrity test indicates a possible lead integrity issue.